Glucosamine Capsules (Novacare) – Inadequate Labeling (2015)
Class II: A situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Class II recall indicates potential for temporary health effects.
This AI-generated summary is provided for general informational purposes only and is derived from publicly available recall notices. It supplements but does not replace official agency classifications or safety instructions.
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
Glucosamine 750 mg 120 ct, Capsule, Dosage: 12 capsules, 750 mg ea., three times daily with meals
Brand
Novacare, LLC
Lot Codes / Batch Numbers
Lot #s: 4102801, 2071918.2, 2061401, 2032006
Products Sold
Lot #s: 4102801, 2071918.2, 2061401, 2032006
Novacare, LLC is recalling Glucosamine 750 mg 120 ct, Capsule, Dosage: 12 capsules, 750 mg ea., three times daily with meals due to TSN Labs is conducting a field action on Glucosamine 750 mg 120 ct due to inadequate allergen labeling.. This is a Class I recall, indicating a high risk of serious health consequences. Based on FDA enforcement report.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
TSN Labs is conducting a field action on Glucosamine 750 mg 120 ct due to inadequate allergen labeling.
Recommended Action
Per FDA guidance
Consumers should stop using the product and contact the recalling firm or return it to the place of purchase.
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticePage updated: Jan 6, 2026